BIIB

Biogen Inc.NASDAQHealthcare

$177.34-3.50%ClosedMarket Cap: $26.03B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-04-02	HC Wainwright & Co.	—	Buy	—
2026-04-01	Canaccord Genuity	—	Buy	—
2026-04-01	Oppenheimer	—	Outperform	—
2026-03-17	HSBC	—	Reduce	—
2026-02-23	Freedom Broker	—	Hold	—
2026-02-10	Wedbush	—	Neutral	—
2026-02-09	Guggenheim	—	Buy	—
2026-02-09	HC Wainwright & Co.	—	Buy	—
2026-02-09	Canaccord Genuity	—	Buy	—
2026-02-09	RBC Capital	—	Outperform	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$16.18	$9.36B	23
Sun Dec 31	$17.34	$9.47B	9
Mon Dec 31	$17.96	$9.53B	3
Tue Dec 31	$18.14	$9.60B	3